DIFFUSE LARGE B CELL LYMPHOMA
Clinical trials for DIFFUSE LARGE B CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE LARGE B CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for DIFFUSE LARGE B CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental therapy targets lymphoma that Won't respond
Disease control TerminatedThis study tested whether an experimental drug called SAR444245, either alone or combined with other cancer treatments, could help people whose Hodgkin or diffuse large B-cell lymphoma had returned or stopped responding to previous therapies. It involved adults and adolescents (a…
Matched conditions: DIFFUSE LARGE B CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Early-Stage trial halted for aggressive blood cancer treatment
Disease control TerminatedThis early-stage study tested a combination of three medicines for people with an aggressive type of blood cancer called diffuse large B-cell lymphoma that had returned or stopped responding to prior treatment. The trial was for patients who could not receive a stem cell transpla…
Matched conditions: DIFFUSE LARGE B CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Targeted immunotherapy tested for Tough-to-Treat lymphoma
Disease control TerminatedThis study tested whether the immunotherapy drug pembrolizumab could help adults with a specific type of aggressive lymphoma that had returned or not responded to prior treatments. It focused on patients whose lymphoma cells had a particular genetic change (PD-L1 alteration). The…
Matched conditions: DIFFUSE LARGE B CELL LYMPHOMA
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC